SENORES PHARMACEUTICALS L (SENORES) — Free Cash Flow Generation Index

Latest as of September 2025: -2.99x

SENORES PHARMACEUTICALS L (SENORES) has a Free Cash Flow Generation Index of -2.99x as of September 2025. Free cash flow of Rs-724.70 Million represents -3% of operating cash flow (Rs242.20 Million). Explore SENORES PHARMACEUTICALS L capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

-2.99x

Free Cash Flow / Operating CF

Free Cash Flow

Rs-724.70 Million

INR

Operating Cash Flow

Rs242.20 Million

INR

Capital Expenditures

Rs966.90 Million

INR

SENORES PHARMACEUTICALS L Free Cash Flow Generation Index (2026–2026)

Historical FCF Generation Index trend for SENORES PHARMACEUTICALS L across 1 annual periods. For the full cash flow conversion analysis, see SENORES PHARMACEUTICALS L operating cash flow efficiency.

Annual Free Cash Flow Generation for SENORES PHARMACEUTICALS L (2026–2026)

Year-by-year Free Cash Flow Generation Index for SENORES PHARMACEUTICALS L. Check SENORES total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.

Year	FCG Index	Free Cash Flow (INR)	Operating CF	Capital Expenditures	YoY Change
2026	-3.27x	Rs-2.03 Billion	Rs620.50 Million	Rs2.65 Billion	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).